Identification of drug target candidates of the swine pathogen Actinobacillus pleuropneumoniae by construction of protein–protein interaction network

다국어 초록 (Multilingual Abstract)

Porcine pleuropneumonia caused by Actinobacillus pleuropneumoniae has led to severe economic losses in the pig industry worldwide. A. pleuropneumoniae displays various levels of antimicrobial resistance, leading to the dire need to identify new drug targets. Protein–protein interaction (PPI) network can aid the identification of drug targets by discovering essential proteins during the life of bacteria. The aim of this study is to identify drug target candidates of A. pleuropneumoniae from essential proteins in PPI network. The homologous protein mapping method (HPM) was utilized to construct A. pleuropneumoniae PPI network. Afterwards, the subnetwork centered with H-NS was selected to verify the PPI network using bacterial two-hybrid assays. Drug target candidates were identified from the hub proteins by analyzing the topology of the network using interaction degree and homologous comparison with the pig proteome. An A. pleuropneumoniae PPI network containing 2737 non-redundant interaction pairs among 533 proteins was constructed. These proteins were distributed in 21 COG functional categories and 28 KEGG metabolic pathways. The A. pleuropneumoniae PPI network was scale free and the similar topological tendencies were found when compared with other bacteria PPI network. Furthermore, 56.3% of the H-NS subnetwork interactions were validated. 57 highly connected proteins (hub proteins) were identified from the A.
pleuropneumoniae PPI network. Finally, 9 potential drug targets were identified from the hub proteins, with no homologs in swine. This study provides drug target candidates, which are promising for further investigations to explore lead compounds against A. pleuropneumoniae.

참고문헌 (Reference)

1 Morris JH, "clusterMaker: a multi-algorithm clustering plugin for Cytoscape" 12 : 436-, 2011

2 Chiers K, "Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host" 41 : 65-, 2010

3 Raman MP, "Uncovering potential drug targets for tuberculosis using protein networks" 8 : 403-406, 2012

4 Cui T, "Uncovering new signaling proteins and potential drug targets through the interactome analysis of Mycobacterium tuberculosis" 10 : 118-, 2009

5 Fassy F, "UMP kinase from Streptococcus pneumoniae: evidence for co-operative ATP binding and allosteric regulation" 384 : 619-627, 2004

6 Lee SE, "The pyrH gene of Vibrio vulnificus is an essential in vivo survival factor" 75 : 2795-2801, 2007

7 He F, "The prediction of protein-protein interaction networks in rice blast fungus" 9 : 519-, 2008

8 Czudnochowski N, "The mechanism of pseudouridine synthases from a covalent complex with RNA, and alternate specificity for U2605 versus U2604 between close homologs" 42 : 2037-2048, 2014

9 Salwinski L, "The database of interacting proteins: 2004 update" 32 : D449-D451, 2004

10 Tatusov RL, "The COG database: an updated version includes eukaryotes" 4 : 41-, 2003

11 Lees JG, "Systematic computational prediction of protein interaction networks" 8 : 035008-, 2011

12 Doig P, "Screening-based discovery of the first novel ATP competitive inhibitors of the Staphylococcus aureus essential enzyme UMP kinase" 437 : 162-167, 2013

13 Li L, "Screening of Actinobacillus pleuropneumoniae LuxS inhibitors" 67 : 564-571, 2013

14 Albert R, "Scale-free networks in cell biology" 118 : 4947-4957, 2005

15 Li G, "Role of (p)ppGpp in viability and biofilm formation of Actinobacillus pleuropneumoniae S8" 10 : e0141501-, 2015

16 Yan F, "RlmN and Cfr are radical SAM enzymes involved in methylation of ribosomal RNA" 132 : 3953-3964, 2010

17 Bosse JT, "Regulation of pga operon expression and biofilm formation in Actinobacillus pleuropneumoniae by sigmaE and H-NS" 192 : 2414-2423, 2010

18 Robertson D, "Rapid recombination screening to test gene essentiality demonstrates that pyrH is essential in Mycobacterium tuberculosis" 87 : 450-458, 2007

19 Peng X, "Protein-protein interactions: detection, reliability assessment and applications" 2016

20 조사연, "Protein-protein Interaction Networks: from Interactions to Networks" 한국생화학분자생물학회 37 (37): 45-52, 2004

21 Kushwaha SK, "Protein interaction network analysis-approach for potential drug target identification in Mycobacterium tuberculosis" 262 : 284-294, 2010

22 Guo J, "Prediction and characterization of protein-protein interaction network in Xanthomonas oryzae pv. oryzae PXO99 A" 164 : 1035-1044, 2013

23 Han YC, "Prediction and characterization of protein-protein interaction network in Bacillus licheniformis WX-02" 6 : 19486-, 2016

24 Hendriksen RS, "Occurrence of antimicrobial resistance among bacterial pathogens and indicator bacteria in pigs in different European countries from year 2002-2004: the ARBAO-II study" 50 : 19-, 2008

25 Fang FC, "New insights into transcriptional regulation by H-NS" 11 : 113-120, 2008

26 Kim B, "Molecular serotyping and antimicrobial resistance profiles of Actinobacillus pleuropneumoniae isolated from pigs in South Korea" 36 : 137-144, 2016

27 Wang YC, "Molecular characterization of enrofloxacin resistant Actinobacillus pleuropneumoniae isolates" 142 : 309-312, 2010

28 Kim SK, "Molecular analysis of the phoH gene, belonging to the phosphate regulon in Escherichia coli" 175 : 1316-1324, 1993

29 Jeong H, "Lethality and centrality in protein networks" 411 : 41-42, 2001

30 Varjosalo M, "Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS" 10 : 307-314, 2013

31 Hasan MA, "Identification of putative drug targets in Vancomycinresistant Staphylococcus aureus (VRSA) using computer aided protein data analysis" 575 : 132-143, 2015

32 Bhattacharyya M, "Identification of important interacting proteins (IIPs) in Plasmodium falciparum using largescale interaction network analysis and in-silico knock-out studies" 14 : 1-17, 2015

33 Fuller TE, "Identification of Actinobacillus pleuropneumoniae virulence genes using signature-tagged mutagenesis in a swine infection model" 29 : 39-51, 2000

34 Miyabe I, "Histone-like protein HU is required for recA gene-dependent DNA repair and SOS induction pathways in UV-irradiated Escherichia coli" 76 : 43-49, 2000

35 Dame RT, "HU: promoting or counteracting DNA compaction?" 529 : 151-156, 2002

36 Wang Y, "Global protein-protein interaction network in the human pathogen Mycobacterium tuberculosis H37Rv" 9 : 6665-6677, 2010

37 Sassetti CM, "Genes required for mycobacterial growth defined by high density mutagenesis" 48 : 77-84, 2003

38 Altschul SF, "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs" 25 : 3389-3402, 1997

39 Braun P, "Evidence for network evolution in an Arabidopsis interactome map" 333 : 601-607, 2011

40 Wishart DS, "DrugBank: a comprehensive resource for in silico drug discovery and exploration" 34 : D668-D672, 2006

41 Segers K, "Development of a high-throughput screening assay for the discovery of small-molecule SecA inhibitors" 413 : 90-96, 2011

42 Tayler NM, "DNA repair mechanisms as drug targets in prokaryotes" 5 : 1206-1232, 2011

43 Xenarios I, "DIP: the database of interacting proteins: 2001 update" 29 : 239-241, 2001

44 Luo H, "DEG 10, an update of the database of essential genes that includes both protein-coding genes and noncoding genomic elements" 42 : D574-D580, 2014

45 Assenov Y, "Computing topological parameters of biological networks" 24 : 282-284, 2008

46 von Mering C, "Comparative assessment of large-scale data sets of protein-protein interactions" 417 : 399-403, 2002

47 Kalia D, "ChemInform Abstract: nucleotide, c-di-GMP, c-di-AMP, cGMP, cAMP, (p)ppGpp signaling in bacteria and implications in pathogenesis" 44 : 305-341, 2013

48 Kazakov AE, "Bioinformatics classification and functional analysis of PhoH homologs" 3 : 3-15, 2003

49 Papanikou E, "Bacterial protein secretion through the translocase nanomachine" 5 : 839-851, 2007

50 Kim B, "Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Korea using new standardized procedures" 63 : 341-, 2001

51 Chang CF, "Antimicrobial susceptibility and plasmid analysis of Actinobacillus pleuropneumoniae isolated in Taiwan" 84 : 169-177, 2002

52 Dayao DA, "Antimicrobial resistance in bacteria associated with porcine respiratory disease in Australia" 171 : 232-235, 2014

53 Kang M, "Analysis of an Actinobacillus pleuropneumoniae multi-resistance plasmid, pHB0503" 61 : 135-139, 2009

54 Tarassov K, "An in vivo map of the yeast protein interactome" 320 : 1465-1470, 2008

55 Bosse JT, "Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection" 4 : 225-235, 2002

56 Sancar A, "A novel repair enzyme: UVRABC excision nuclease of Escherichia coli cuts a DNA strand on both sides of the damaged region" 33 : 249-260, 1983

57 Schwikowski B, "A network of protein-protein interactions in yeast" 18 : 1257-1261, 2000